Journal article
Review and Consensus on Pharmacogenomic Testing in Psychiatry
CA Bousman, SA Bengesser, KJ Aitchison, AT Amare, H Aschauer, BT Baune, BB Asl, JR Bishop, M Burmeister, B Chaumette, LS Chen, ZA Cordner, J Deckert, F Degenhardt, LE Delisi, L Folkersen, JL Kennedy, TE Klein, JL McClay, FJ McMahon Show all
Pharmacopsychiatry | Published : 2021
DOI: 10.1055/a-1288-1061
Abstract
The implementation of pharmacogenomic (PGx) testing in psychiatry remains modest, in part due to divergent perceptions of the quality and completeness of the evidence base and diverse perspectives on the clinical utility of PGx testing among psychiatrists and other healthcare providers. Recognizing the current lack of consensus within the field, the International Society of Psychiatric Genetics assembled a group of experts to conduct a narrative synthesis of the PGx literature, prescribing guidelines, and product labels related to psychotropic medications as well as the key considerations and limitations related to the use of PGx testing in psychiatry. The group concluded that to inform medi..
View full abstractGrants
Awarded by National Institutes of Health
Funding Acknowledgements
The work was supported in part by an Alberta Innovates Strategic Research Project G2018000868 (Drs. Aitchison and Bousman), the Neuroscience and Mental Health Institute and Department of Psychiatry, University of Alberta (Ms. Behroozi Asi), NARSAD Young Investigator Grant from the Brain & Behaviour Research Foundation (Dr. Amare), the Foundation Bettencourt-Schueller (Dr. Chaumette), the European COST Action EnGagE CA17130 (Dr. Degenhardt), the German Federal Ministry of Education and Research e: Med programme (Dr. Degenhardt), the NIH/NHGRI U24 HG010615 (Drs. Klein and Sangkuhl), the NIH/NIGMS R24 GM123930 (Dr. Gaedigk), the NIDA R01 DA038076 (Dr. Li-Shiun), and the NIMH Intramural Research Program (Dr. McMahon).